Healthcare Realty: Insights on Dividend and Recent Developments Before Aug 14, 2025
Generado por agente de IAAinvest Dividend Digest
domingo, 10 de agosto de 2025, 10:02 pm ET1 min de lectura
HR--
Healthcare Realty (HR) has announced its latest dividend details, with an ex-dividend date set for Aug 14, 2025, and a payout date on Aug 28, 2025. The dividend per share stands at $0.240, significantly lower than the average of the last ten dividends, which was $0.350. Previously, HRHR-- distributed $0.310 per share on May 23, 2025. The company consistently adopts cash dividends as its dividend type.
Recently, Healthcare Realty TrustHR-- has been actively repositioning itself through strategic measures such as capital discipline, asset optimization, and balance sheet restructuring. These efforts are aimed at unlocking value for shareholders. Analysts have highlighted a cautious hold rating on HR, noting its positive growth prospects amidst strategic challenges. The company reported a robust Q2 normalized FFO of $0.410, surpassing consensus estimates of $0.400, with revenues slightly below expectations at $297.500 million. Furthermore, HR has raised its FY25 normalized FFO view, indicating a promising outlook.
Over the past week, Healthcare RealtyHR-- Trust has seen significant developments that could impact its operations and market performance. Recently, the company announced a new credit facility agreement on Jul 31, 2025, aiming to strengthen its financial position. Additionally, HR's recent earnings call highlighted robust growth and strategic challenges, contributing to a mixed outlook. The stock price target was recently adjusted from $18 to $17 by analysts, reflecting the current market sentiment and financial health of the company.
In conclusion, Healthcare Realty Trust is navigating through a period of strategic transformation and financial adjustments. Investors interested in securing the upcoming dividend should note that Aug 14, 2025, is the last day to purchase HR's stock to be eligible for this dividend distribution. Purchases made after this date will not qualify for the current dividend payout.
Recently, Healthcare Realty TrustHR-- has been actively repositioning itself through strategic measures such as capital discipline, asset optimization, and balance sheet restructuring. These efforts are aimed at unlocking value for shareholders. Analysts have highlighted a cautious hold rating on HR, noting its positive growth prospects amidst strategic challenges. The company reported a robust Q2 normalized FFO of $0.410, surpassing consensus estimates of $0.400, with revenues slightly below expectations at $297.500 million. Furthermore, HR has raised its FY25 normalized FFO view, indicating a promising outlook.
Over the past week, Healthcare RealtyHR-- Trust has seen significant developments that could impact its operations and market performance. Recently, the company announced a new credit facility agreement on Jul 31, 2025, aiming to strengthen its financial position. Additionally, HR's recent earnings call highlighted robust growth and strategic challenges, contributing to a mixed outlook. The stock price target was recently adjusted from $18 to $17 by analysts, reflecting the current market sentiment and financial health of the company.
In conclusion, Healthcare Realty Trust is navigating through a period of strategic transformation and financial adjustments. Investors interested in securing the upcoming dividend should note that Aug 14, 2025, is the last day to purchase HR's stock to be eligible for this dividend distribution. Purchases made after this date will not qualify for the current dividend payout.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios